Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Abiochem Biotechnology
company
About
Abiochem Biotechnology is a genetic and enzyme engineering technology company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Agriculture,AgTech,Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products, pesticides, etc., and has contributed to the promotion and development of green chemistry.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Abiochem Biotechnology has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Nov 28, 2020 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 28, 2020 | Series A | — | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Abiochem Biotechnology is funded by 2 investors.
Haitong-Fortis Private Equity Fund Management
and Zizhu Xiaomiao Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Haitong-Fortis Private Equity Fund Management
|
— | Series A |
Zizhu Xiaomiao Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
